Literature DB >> 8660844

Membrane form of TNF alpha induces both cell lysis and apoptosis in susceptible target cells.

G Monastra1, A Cabrelle, A Zambon, A Rosato, B Macino, D Collavo, P Zanovello.   

Abstract

Tumor necrosis factor alpha, in the secreted as well as membrane-associated (mTNF alpha) form, represents a cytotoxic effector mechanism of activated macrophages; in contrast, direct evidence of the mTNF alpha involvement in cytotoxic T lymphocyte (CTL)-mediated lysis has not yet been obtained. We observed that following activation with anti-CD3 monoclonal antibody (mAb), both cloned CTL and peritoneal exudate lymphocytes rapidly upregulated mTNF alpha; a similar effect was observed in the macrophage cell line J774 after stimulation with lipopolysaccharide endotoxin. Activated effector cells, which were fixed with paraformaldehyde before testing, exerted lytic activity against the TNF-sensitive WEHI 164 tumor cell line, but not against the TNF-resistant P-815 mastocytoma. This effect was completely inhibited in the presence of anti-mouse TNF alpha Ab. Moreover, both mTNF alpha-expressing macrophages and CTL induced nuclear DNA fragmentation in WEHI 164 cells, which was also blocked by anti-TNF alpha Ab and was accompanied by a morphologic degeneration characteristic of the apoptotic form of cell death. These data on the whole indicate a common mode of action for mTNF alpha expressed on different cell populations endowed with cytotoxic capability and also imply a role for this molecule in T-cell-mediated cytotoxicity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8660844     DOI: 10.1006/cimm.1996.0179

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  8 in total

1.  CD40 expression in Wehi-164 cell line.

Authors:  Mohammad Hossein Karimi; Padideh Ebadi; Ali Akbar Pourfathollah; Zahra Soheila Soheili; Seyed Mohammad Moazzeni
Journal:  Cytotechnology       Date:  2010-05-23       Impact factor: 2.058

2.  Peptide vaccination of mice immune to LCMV or vaccinia virus causes serious CD8 T cell-mediated, TNF-dependent immunopathology.

Authors:  Fei Liu; Ralph Feuer; Daniel E Hassett; J Lindsay Whitton
Journal:  J Clin Invest       Date:  2006-01-19       Impact factor: 14.808

3.  Macrophage infiltration, but not apoptosis, is correlated with immune-mediated demyelination following murine infection with a neurotropic coronavirus.

Authors:  G F Wu; S Perlman
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

4.  Toxoplasma gondii-infected human myeloid dendritic cells induce T-lymphocyte dysfunction and contact-dependent apoptosis.

Authors:  Shuang Wei; Florentina Marches; Jozef Borvak; Weiping Zou; Jacqueline Channon; Michael White; Jay Radke; Marie-France Cesbron-Delauw; Tyler J Curiel
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

5.  Multifaceted inhibition of anti-tumour immune mechanisms by soluble tumour necrosis factor receptor type I.

Authors:  C L Selinsky; K L Boroughs; W A Halsey; M D Howell
Journal:  Immunology       Date:  1998-05       Impact factor: 7.397

6.  A role for TNF receptor type II in leukocyte infiltration into the lung during experimental idiopathic pneumonia syndrome.

Authors:  Gerhard C Hildebrandt; Krystyna M Olkiewicz; Leigh Corrion; Shawn G Clouthier; Elizabeth M Pierce; Chen Liu; Kenneth R Cooke
Journal:  Biol Blood Marrow Transplant       Date:  2008-04       Impact factor: 5.742

Review 7.  Use of the tumor necrosis factor-blockers for Crohn's disease.

Authors:  Alan B R Thomson; Milli Gupta; Hugh J Freeman
Journal:  World J Gastroenterol       Date:  2012-09-21       Impact factor: 5.742

8.  Role of tumor necrosis factor alpha (TNF-alpha) and interleukin-10 in the pathogenesis of severe murine monocytotropic ehrlichiosis: increased resistance of TNF receptor p55- and p75-deficient mice to fatal ehrlichial infection.

Authors:  Nahed Ismail; Heather L Stevenson; David H Walker
Journal:  Infect Immun       Date:  2006-03       Impact factor: 3.441

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.